Fabio Cappuccini

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 272 citations · Full text

Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients.

Tetsuya Gatanaga, Chanseong Hwang, William J. Kohr et al. · Proceedings of the National Academy of Sciences · 1990 · 154 citations · Full text

Immunotoxicology, Immunology, Pathology +18

Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy

Krishnansu S. Tewari, Fabio Cappuccini, Angela Gambino et al. · Cancer · 1998 · 129 citations · Full text

Obstetric emergencies precipitated by malignant brain tumors

Krishnansu S. Tewari, Fabio Cappuccini, Tamerou Asrat et al. · American Journal of Obstetrics and Gynecology · 2000 · 107 citations · Full text

Neuro-oncology, Pediatric Brain Tumors, Abortion +7

Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay–guided chemotherapy

Vera Loizzi, John K. Chan, Kathryn Osann et al. · American Journal of Obstetrics and Gynecology · 2003 · 90 citations

Survival Outcomes, Medicine, Cancer Recurrence +8